miR-449a targets HDAC-1 and induces growth arrest in prostate cancer (Q39878284)

15 September 2017

title

miR-449a targets HDAC-1 and induces growth arrest in prostate cancer (English)

1 reference

15 September 2017

1 reference

E J Noonan

1

1 reference

15 September 2017

R F Place

2

1 reference

15 September 2017

D Pookot

3

1 reference

15 September 2017

S Basak

4

1 reference

15 September 2017

J M Whitson

5

1 reference

15 September 2017

H Hirata

6

1 reference

15 September 2017

C Giardina

7

1 reference

15 September 2017

R Dahiya

8

1 reference

15 September 2017

language of work or name

English

0 references

publication date

2 March 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

28

1 reference

15 September 2017

issue

14

1 reference

15 September 2017

page(s)

1714-1724

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2009.19

15 September 2017

exact match

0 references

cites work

Trichostatin A induces apoptosis in lung cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway?

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Posttranscriptional gene silencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

A biomarker that identifies senescent human cells in culture and in aging skin in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Characterization of microRNA expression levels and their biological correlates in human cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

MicroRNA targeting specificity in mammals: determinants beyond seed pairing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

A microRNA component of the p53 tumour suppressor network

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

p15INK4b in HDAC inhibitor‐induced growth arrest

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Inhibition of Histone Deacetylase Class I but not Class II Is Critical for the Sensitization of Leukemic Cells to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Real-time expression profiling of microRNA precursors in human cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

The human genome browser at UCSC

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Downregulation of gelsolin and retinoic acid receptor beta expression in gastric cancer tissues through histone deacetylase 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Prediction of mammalian microRNA targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

MicroRNA expression profiles classify human cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Histone deacetylases and cancer: causes and therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Histone deacetylase inhibitors: biology and mechanism of action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Widespread deregulation of microRNA expression in human prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Histone deacetylase and DNA methyltransferase in human prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

MicroRNA-373 induces expression of genes with complementary promoter sequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

HDACs and the senescent phenotype of WI-38 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

MicroRNA expression profiling in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Transcriptional activation of miR-34a contributes to p53-mediated apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Role for histone deacetylase 1 in human tumor cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Let-7 expression defines two differentiation stages of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

HDAC3 overexpression and colon cancer cell proliferation and differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

A microRNA expression signature of human solid tumors defines cancer gene targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Histone deacetylases in replicative senescence: evidence for a senescence-specific form of HDAC-2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Genome‐wide scan of Swedish families with hereditary prostate cancer: Suggestive evidence of linkage at 5q11.2 and 19p13.3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Histone deacetylase inhibitors: molecular mechanisms of action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.19

31 March 2020

Identifiers

DOI

10.1038/ONC.2009.19

1 reference

15 September 2017

1 reference